Martina Flammer
Vermögen: 6 Mio $ am 30.06.2026
Vermögen: 6 Mio $ am 30.06.2026
Martina Flammer is currently Chief Medical Officer at Insmed, Inc., a position held since 2019.
Formerly, worked at Boehringer Ingelheim International GmbH from 2012 to 2019, serving as SVP & Head-Corporate Division Customer Value from 2018 to 2019.
Also worked at Boehringer Ingelheim (Canada) Ltd. from 2012 to 2018, holding the title VP-Clinical Development & Medical Affairs from 2016 to 2018.
Education includes a doctorate from the Medical University of Vienna and an MBA from The Leonard N Stern School of Business.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
INSMED INCORPORATED 0,03 % | 06.07.2026 | 60.486 ( 0,03 % ) | 6 Mio $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| INSMED INCORPORATED | Technik-/Wissenschafts-/F&E-Leiter | 19.12.2019 |
| Unternehmen | Position | Ende |
|---|---|---|
Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH Pharmaceuticals: MajorHealth Technology Engages in development, manufacturing and marketing of medicines for humans & animals | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2014 |
Boehringer Ingelheim (Canada) Ltd.
Boehringer Ingelheim (Canada) Ltd. BiotechnologyHealth Technology Engages in researching and development of new drugs and treatments | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2018 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Insmed, Inc.
Insmed, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases | Health Technology |
Medical University of Vienna
Medical University of Vienna Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH Pharmaceuticals: MajorHealth Technology Engages in development, manufacturing and marketing of medicines for humans & animals | Health Technology |
Boehringer Ingelheim (Canada) Ltd.
Boehringer Ingelheim (Canada) Ltd. BiotechnologyHealth Technology Engages in researching and development of new drugs and treatments | Health Technology |
The Leonard N Stern School of Business
The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen